AnaptysBio, Inc. (ANAB) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About AnaptysBio, Inc.
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the…
Source: Yahoo Finance
Sector & Industry
AnaptysBio, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
AnaptysBio, Inc. at a Glance
| Company | AnaptysBio, Inc. |
| Ticker | ANAB |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $56.80 |
| Market cap | $1.68B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.02 |
| 52-week high | $72.36 |
| 52-week low | $11.40 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.41 |
| Return on equity (ROE) | -114.55% |
| Debt-to-equity | 2175.84% |
| Average volume | 590,336 |
| Shares outstanding | 29.61M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 104 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is AnaptysBio, Inc.'s current P/E ratio?
- AnaptysBio, Inc. (ANAB) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is AnaptysBio, Inc.'s market capitalisation?
- AnaptysBio, Inc.'s market cap is $1.68B based on our latest snapshot. See how it ranks by market cap →
- What is ANAB's 52-week range?
- Over the past 52 weeks, ANAB has traded between $11.40 and $72.36. What does the 52-week range mean? →
- How volatile is AnaptysBio, Inc. compared to the market?
- AnaptysBio, Inc. has a beta of 0.41, meaning it has historically moved less than the broader market. What does beta measure? →
- Does AnaptysBio, Inc. pay a dividend?
- AnaptysBio, Inc. does not currently pay a dividend according to our latest data.
- What exchange is ANAB listed on?
- ANAB is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is AnaptysBio, Inc. in?
- AnaptysBio, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →